Literature DB >> 16477056

Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort.

Kenny W J Lee1, John S Hill, Keith R Walley, Jiri J Frohlich.   

Abstract

BACKGROUND: Although elevated levels of C-reactive protein (CRP), interleukin (IL)-6, serum amyloid A protein (SAA) and total homocysteine (tHcy) have been associated with the increased likelihood of cardiovascular events, the relative or combined utility of these biomarkers in predicting atherosclerosis and death in an angiography cohort is unknown.
METHODS: A cohort of 1117 consecutive patients (797 men and 320 women), referred to 2 Vancouver teaching hospitals for selective coronary angiography, was recruited between 1993 and 1995. Angiography results were obtained for 1019 patients. In 2004 we determined that of 1050 patients who could be traced, 231 had died, 95 of CAD-related causes. We compared the relative utility of baseline measurements of CRP, IL-6, SAA and tHcy as well as of lipids for predicting angiographic CAD and all-cause and CAD-related death.
RESULTS: The risk of death increased across quartiles for CRP, IL-6, SAA and tHcy. When comparing the highest and lowest quartiles, the greatest hazard ratios were associated with IL-6 (2.57, 95% confidence interval [CI] 1.62-4.09) and tHcy (2.36, 95% CI 1.53-3.65). A Cox regression model containing all plasma biomarkers and traditional risk factors indicated that age, angiographic CAD and baseline plasma levels of IL-6 and tHcy remained independent predictors of CAD-related death, whereas age, sex, smoking, diabetes and apolipoprotein B levels were independent predictors of angiographic CAD. Kaplan-Meier survival curves indicated a utility in combining measures of CRP, SAA, IL-6 and tHcy for predicting risk of all-cause and CAD-related death.
INTERPRETATION: A comparison of elevated levels of CRP, IL-6, SAA and tHcy with traditional CAD risk factors indicated that IL-6 and tHcy were the strongest independent biomarkers for CAD-related death. Elevated levels of multiple biomarkers were associated with an increasing rate of all-cause and CAD-related death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477056      PMCID: PMC1373750          DOI: 10.1503/cmaj.050880

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  40 in total

Review 1.  Inflammation in cardiovascular disease: cart, horse or both--revisited.

Authors:  Russell P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

2.  Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid.

Authors:  Emmanouil S Brilakis; Joseph P McConnell; Karla V Ballman; George G Klee; Peter B Berger
Journal:  Atherosclerosis       Date:  2002-12       Impact factor: 5.162

3.  C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.

Authors:  James S Zebrack; Joseph B Muhlestein; Benjamin D Horne; Jeffrey L Anderson
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

4.  Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy.

Authors:  E Lindmark; E Diderholm; L Wallentin; A Siegbahn
Journal:  JAMA       Date:  2001-11-07       Impact factor: 56.272

5.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors: 
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

6.  Coronary artery disease in patients at low risk--apolipoprotein AI as an independent risk factor.

Authors:  M C Francis; J J Frohlich
Journal:  Atherosclerosis       Date:  2001-03       Impact factor: 5.162

7.  Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study.

Authors:  S E Vollset; H Refsum; A Tverdal; O Nygård; J E Nordrehaug; G S Tell; P M Ueland
Journal:  Am J Clin Nutr       Date:  2001-07       Impact factor: 7.045

8.  Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.

Authors:  Edmund A Bermudez; Nader Rifai; Julie Buring; JoAnn E Manson; Paul M Ridker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

9.  Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death.

Authors:  Christine M Albert; Jing Ma; Nader Rifai; Meir J Stampfer; Paul M Ridker
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

10.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

Authors:  David S Wald; Malcolm Law; Joan K Morris
Journal:  BMJ       Date:  2002-11-23
View more
  8 in total

1.  The association between elevated levels of inflammation biomarkers and coronary artery disease and death.

Authors:  Gordon D O Lowe
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

Review 2.  Association between serum amyloid A and obesity: a meta-analysis and systematic review.

Authors:  Yulan Zhao; Xuelian He; Xuegui Shi; Chengjin Huang; Jie Liu; Shuli Zhou; Chew-Kiat Heng
Journal:  Inflamm Res       Date:  2010-02-07       Impact factor: 4.575

3.  Improving mortality prediction using biosocial surveys.

Authors:  Noreen Goldman; Dana A Glei; Yu-Hsuan Lin; Maxine Weinstein
Journal:  Am J Epidemiol       Date:  2009-01-15       Impact factor: 4.897

4.  Beyond Self-Reports: Changes in Biomarkers as Predictors of Mortality.

Authors:  Dana A Glei; Noreen Goldman; Germán Rodríguez; Maxine Weinstein
Journal:  Popul Dev Rev       Date:  2014-06-01

5.  gamma-Aminbuturic acid A receptor mitigates homocysteine-induced endothelial cell permeability.

Authors:  Neetu Tyagi; Karni S Moshal; Suresh C Tyagi; David Lominadze
Journal:  Endothelium       Date:  2007 Nov-Dec

6.  A method to study the effect of bronchodilators on smoke retention in COPD patients: study protocol for a randomized controlled trial.

Authors:  W D van Dijk; P T J Scheepers; R Cremers; J W M Lenders; W Klerx; C van Weel; T R J Schermer; Y Heijdra
Journal:  Trials       Date:  2011-02-10       Impact factor: 2.279

7.  Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages.

Authors:  Jenny Persson; Jan Nilsson; Marie W Lindholm
Journal:  Lipids Health Dis       Date:  2006-06-26       Impact factor: 3.876

8.  Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of serum amyloid A as a potential marker.

Authors:  Antonio J Lepedda; Gabriele Nieddu; Elisabetta Zinellu; Pierina De Muro; Franco Piredda; Anna Guarino; Rita Spirito; Franco Carta; Francesco Turrini; Marilena Formato
Journal:  Oxid Med Cell Longev       Date:  2013-12-24       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.